UBS Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
1,171,619
+238,513
| +26% | +$890K | ﹤0.01% | 3176 |
|
|
2025
Q1 | $2.58M | Buy |
933,106
+531,448
| +132% | +$1.47M | ﹤0.01% | 3524 |
|
|
2024
Q4 | $2.23M | Buy |
401,658
+332,260
| +479% | +$1.84M | ﹤0.01% | 3636 |
|
|
2024
Q3 | $579K | Sell |
69,398
-17,934
| -21% | -$150K | ﹤0.01% | 3990 |
|
|
2024
Q2 | $595K | Buy |
87,332
+24,563
| +39% | +$167K | ﹤0.01% | 3810 |
|
|
2024
Q1 | $412K | Sell |
62,769
-45,706
| -42% | -$300K | ﹤0.01% | 4237 |
|
|
2023
Q4 | $704K | Buy |
108,475
+86,931
| +404% | +$564K | ﹤0.01% | 3707 |
|
|
2023
Q3 | $108K | Sell |
21,544
-31,531
| -59% | -$159K | ﹤0.01% | 4670 |
|
|
2023
Q2 | $464K | Buy |
53,075
+47,403
| +836% | +$415K | ﹤0.01% | 3883 |
|
|
2023
Q1 | $67.2K | Buy |
+5,672
| New | +$67.2K | ﹤0.01% | 5147 |
|
|
2022
Q4 | – | Sell |
-3,667
| Closed | -$22K | – | 9815 |
|
|
2022
Q3 | $22K | Buy |
+3,667
| New | +$22K | ﹤0.01% | 6179 |
|
|
2022
Q1 | – | Sell |
-3,775
| Closed | -$27K | – | 9606 |
|
|
2021
Q4 | $27K | Buy |
+3,775
| New | +$27K | ﹤0.01% | 6393 |
|
|
2021
Q2 | – | Sell |
-2,546
| Closed | -$56K | – | 8589 |
|
|
2021
Q1 | $56K | Buy |
+2,546
| New | +$56K | ﹤0.01% | 5434 |
|